欧戈氨酸在骨肌肉和脂肪组织中的分布特征
Kentaro Nishioka1, Takahiro Ishimoto1, Makoto Katsube1
1Faculty of Pharmacy, Kanazawa University, Kakuma-machi, Kanazawa, 920-1192, Japan.
Biochemical and biophysical research communications
|June 21, 2025
概括
埃尔戈氨酸 (EGT) 在小鼠组织中分布不均. 抗氧化剂EGT更多地集中在肌肉和棕色脂肪组织 (iBAT) 中,这表明组织特定的作用和潜在的益处.
科学领域:
- 营养生物化学 营养生物化学
- 分子生物学分子生物学
- 生理学 生理学 生理学
背景情况:
- 欧戈氨酸 (EGT) 是一种由OCTN1.1运输的食物衍生氨基酸.
- 在骨肌肉和脂肪组织中EGT的分布尚不清楚.
- 了解组织特异性EGT吸收对于其健康应用至关重要.
研究的目的:
- 研究EGT在不同骨肌肉和脂肪组织中的分布.
- 为了检查EGT载体OCTN1在这些组织中的表达.
- 探索 EGT 分布差异的潜在原因.
主要方法:
- 口服EGT (20mg/kg/天) 给中年雄性C57BL/6J小鼠,长达56天.
- 量化 EGT 度在肌底肌,腹肌肌,腹肌肌, epididymal 白脂肪组织 (eWAT) 和骨间棕色脂肪组织 (iBAT).
- 在相同的组织中测量OCTN1mRNA表达水平.
主要成果:
- 与胃口肌和植物肌相比,在肌肉肌中发现了显著更高的EGT度.
- 在肌肉中,OCTN1mRNA的表达也显著地更高.
- 在iBAT中EGT度明显高于eWAT.
结论:
- EGT在骨肌肉和脂肪组织中表现出独特的分布模式.
- 唯一肌肉和IBAT显示了EGT的优先积累.
- 在soleus和iBAT中较高的氧化压力可能会推动EGT的积累,突出其抗氧化作用.
相关概念视频
Drug Distribution: Tissue Binding
3.2K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
3.2K
Classification of Skeletal Muscle Fibers
56.9K
Skeletal muscles continuously produce ATP to provide the energy that enables muscle contractions. Skeletal muscle fibers can be categorized into three types based on differences in their contraction speed and how they produce ATP, as well as physical differences related to these factors. Most human muscles contain all three muscle fiber types, albeit in varying proportions.
Slow-Twitch Muscle Fibers
Slow oxidative, muscle fibers appear red due to large numbers of capillaries and high levels of...
Slow-Twitch Muscle Fibers
Slow oxidative, muscle fibers appear red due to large numbers of capillaries and high levels of...
56.9K
Tissue-Drug Binding: Localization of Drugs and its Significance
174
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
174
Classification of Skeletal Muscle Relaxants
2.7K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.7K
Skeletal Muscle Relaxants: Adverse Effects
485
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
485
Compartment Models: Two-Compartment Model
6.1K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
6.1K


